Santhosh Reddy Meedimale, Consultant Medical Oncologist at Omega Hospitals, shared a post on LinkedIn:
”From Research to Recognition: Proud to Receive the ESMO Merit Award at ESMO TAT Asia 2026, Hong Kong.
I am truly honoured to have presented my research at ESMO TAT Asia 2026 (Targeted Anticancer Therapies), one of the most prestigious international forums dedicated to advancing cancer research and precision oncology.
I am especially humbled to receive the ESMO Merit Award, a recognition that celebrates scientific excellence and innovation in oncology research. Being acknowledged by the global oncology community is both a privilege and a motivation to continue pursuing meaningful research that can improve patient outcomes.
This achievement would not have been possible without the invaluable guidance of my mentors, the support of my colleagues and collaborators, and, most importantly, the trust of the patients who inspire our work every day.
Moments like these remind us that research is not merely about publications and presentations – it is about transforming scientific discoveries into hope and better lives for our patients.
- Grateful for the recognition.
- Inspired by the journey.
- Motivated for what lies ahead.
Thank you, ESMO – European Society for Medical Oncology, for this incredible honour and for fostering a global platform where innovation, collaboration, and excellence continue to shape the future of oncology.”
Other articles featuring Santhosh Reddy Meedimale on OncoDaily.
